The most common serious side effects of Tislelizumab treatment

Tislelizumab (Tislelizumab), as a new type of PD-1 immune checkpoint inhibitor, is widely used in the immunotherapy of various tumors. Although it has outstanding performance in improving patient survival rate and treatment effect, it is also accompanied by certain risks of side effects during clinical use, especially some serious immune-related adverse reactions. Understanding and mastering these common serious side effects is crucial for safe medication use and timely intervention for patients.

One of the most common serious side effects of tislelizumab is immune-related pneumonitis. This lung inflammation is caused by an overactivated immune system that attacks normal lung tissue. Patients may have symptoms such as cough, difficulty breathing, and fever, which can lead to respiratory failure in severe cases. Although the incidence of pneumonia is not particularly high, once it occurs, the drug needs to be stopped immediately and immunosuppressive treatment such as glucocorticoids given to prevent the condition from worsening.

Liver damage is also a common serious side effect of tislelizumab. Immune-mediated hepatitis may manifest as significantly elevated transaminases, and patients may develop symptoms such as jaundice and fatigue. If not treated in time, liver damage may further aggravate and even lead to liver failure. Therefore, liver function indicators need to be monitored regularly during treatment, and treatment plans should be adjusted promptly if abnormalities are found.

Tislelizumab may also cause immune enteritis, manifested by diarrhea, abdominal pain, and intestinal inflammation. This inflammation may seriously affect the patient's quality of life. If the symptoms are severe, hospitalization may be required, and medication and immunosuppressive agents may be discontinued if necessary. Timely identification and treatment of immune enteritis can help reduce the risk of complications for patients and ensure the safety of treatment.

In summary, the serious side effects of tislelizumab treatment mainly include immune-related pneumonia, liver function damage, and immune enteritis. Patients and doctors should pay close attention to these adverse reactions, regularly monitor relevant indicators, and deal with abnormalities in a timely manner to ensure patient medication safety and therapeutic effects.

Reference materials:https://www.drugs.com